Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.
Withaferin A (WFA) is a natural product that binds to soluble forms of the type III intermediate filament (IF) vimentin. Currently, it is unknown under what pathophysiological contexts vimentin is druggable, as cytoskeltal vimentin-IFs are abundantly expressed. To investigate druggability of vimenti...
Guardado en:
Autores principales: | Paola Bargagna-Mohan, Sunil P Deokule, Kyle Thompson, John Wizeman, Cidambi Srinivasan, Sunil Vooturi, Uday B Kompella, Royce Mohan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d42ba520c0441daa78792964c03f0a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
por: Vidhi Malik, et al.
Publicado: (2021) -
Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane
por: Renu Wadhwa, et al.
Publicado: (2021) -
Highly efficient human serum filtration with water-soluble nanoporous nanoparticles
por: Antonella Pujia, et al.
Publicado: (2010) -
Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011) -
EX-PRESS Glaucoma Filtration Device: efficacy, safety, and predictability
por: Chan JE, et al.
Publicado: (2015)